Validation of assay indicating method development of meloxicam in bulk and some of its tablet dosage forms by RP-HPLC


A novel, simple and economic reverse phase high performance liquid chromatography (RP-HPLC) method has been developed for the quantification of Meloxicam in bulk and tablet dosage form with greater precision and accuracy. Separation was achieved on Develosil ODS HG-5 RP C18, (15cm x 4.6 mm i.d.

5mum) column in isocratic mode with mobile phase consisting of acetonitrile :phosphate buffer(pH 3.4) (60:40) with a flow rate of 1 mL/min. The detection was carried out at 268 nm.

The retention time of Meloxicam was found to be 2.09 min.The method was validated as per ICH guidelines. Linearity was established for Meloxicam in the range 20 – 120 mug / ml with R2 value 0.996.

The percentage recovery of Meloxicam was found to be in the range 99.99-100.46%. The high recovery and low relative standard deviation confirm the suitability of the proposed method for the estimation of the drug in bulk and tablet dosage forms.

Validation studies demonstrated that the proposed RP-HPLC method is simple, specific, rapid, reliable and reproducible for the determination of Meloxicam for Quality Control level.

Author: Nalini Kanta SahooMadhusmita SahuPodilapu Srinivasa RaoN Sandhya RaniJNV Indira DeviGoutam Ghosh
Credits/Source: SpringerPlus 2014, 3:95

Published on: 2014-02-18

Tweet

News Provider: EUPB – European Press Bureau

Social Bookmarking
RETWEET This! | Digg this! | Post to del.icio.us | Post to Furl | Add to Netscape | Add to Yahoo! | Rojo

There are no comments available. Be the first to write a comment.